Variable | Before intervention | After intervention | P value |
---|---|---|---|
Office systolic BP (mmHg) | 171 ± 15.8 | 130 ± 10.6 | < 0.0001 |
Office diastolic BP (mmHg) | 101 ± 11.5 | 80 ± 8.7 | < 0.0001 |
Daytime average systolic BP (mmHg) | 164 ± 12.2 | 134 ± 10.8 | < 0.0001 |
Daytime average diastolic BP (mmHg) | 93 ± 10.1 | 78 ± 6.8 | < 0.0001 |
Heart rate (bpm) | 69 ± 10.9 | 66 ± 9.6 | 0.024 |
BMI (kg/m2) | 30.0 ± 5.9 | 29.9 ± 5.5 | 0.79 |
Current smoker (n) | 2 (7%) | 2 (7%) | 1.00^ |
Alcohol (units/week) | 7 (1–15) | 2 (1–10) | 0.36§ |
Angiotensin receptor blocker (n) | 0 | 25 (83%) | n/a |
Calcium channel blocker (n) | 0 | 29 (97%) | n/a |
Thiazide diuretic (n) | 0 | 15 (50%) | n/a |
Aldosterone antagonist (n) | 0 | 4 (13%) | n/a |
α-blocker (n) | 0 | 1 (3%) | n/a |
β-blocker (n) | 0 | 1 (3%) | n/a |
Number of anti-hypertensives (n) | 0 | 2.5 (2–3) | n/a |
Number of other medications (n) | 0 (0–1) | 0 (0–1) | 0.32§ |
Number of co-morbidities (n) | 1.0 ± 0.9 | 1.0 ± 0.9 | 1.00 |